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To assess the species distribution and epidemiologic 
trends of nontuberculous mycobacteria, we examined iso-
lates from patients in Taiwan. During 2000–2008, the pro-
portion increased signiﬁ  cantly from 32.3% to 49.8%. Asso-
ciated disease incidence increased from 2.7 to 10.2 cases 
per 100,000 patients. Mycobacterium avium complex and 
M. abscessus were most frequently isolated.
I
n Taiwan, the incidence of tuberculosis (TB) remains 
high despite advances in the antimycobacterial therapy 
and implementation of well-known TB control measures 
(1). Therefore, patients with acid-fast bacilli (AFB)–posi-
tive specimens, especially respiratory samples, are general-
ly presumed to be infected with Mycobacterium tuberculo-
sis and are treated with antituberculosis agents and placed 
in isolation rooms. Increased isolation of nontuberculous 
mycobacteria (NTM) causing mycobacterial diseases (2,3) 
implies that more patients with AFB-positive samples have 
received inappropriate or unnecessary empirical antituber-
culous treatment. 
To help clinicians determine whether to initiate anti-
tuberculous treatment, mycobacterial laboratories should 
provide percentages of NTM isolates among specimens 
with positive AFB. However, the number and species of 
NTM from clinical specimens are increasing in the clinical 
laboratory, and the distribution of NTM species varies by 
geographic area (4). We thus sought to assess the species 
distribution of NTM isolates from various clinical speci-
mens and to elucidate the epidemiologic trends of NTM 
isolates and diseases over a 9-year period in Taiwan.
The Study
To assess prevalence of NTM isolates, we used the 
database of the National Taiwan University Hospital my-
cobacterial laboratory and prepared clinical specimens for 
mycobacteria cultures according to recommended guide-
lines (5). Before 2001, specimens were spread onto Lowen-
stein-Jensen slants and Middlebrook 7H11 medium (BBL; 
Becton, Dickinson and Company Diagnostic Instrument 
Systems, Sparks, MD, USA); since late 2001, they have 
been spread onto Lowenstein-Jensen slants and tested by 
the ﬂ  uorometric BACTEC system (BACTEC Mycobacteri-
um Growth Indicator Tube 960 system; Becton, Dickinson 
and Company). NTM were identiﬁ  ed to the species level by 
using conventional biochemical methods. Some unidenti-
ﬁ  ed NTM species were further conﬁ  rmed by sequencing of 
their 16S rRNA gene (1,464 bp) by using 2 primers (8FPL 
and 1492) as previously described (6,7). Diseases caused 
by NTM were deﬁ  ned according to previous description 
(4). Annual incidence and isolation ratio of TB and NTM 
over time were evaluated by the Cochran-Armitage test for 
trend. We considered p<0.05 to be signiﬁ  cant. To deﬁ  ne 
NTM disease incidence and prevalence, for patients who 
had isolates over successive years during the study period 
we included only the year in which they ﬁ  rst appeared in 
the laboratory database.
From January 2000 through December 2008, the labo-
ratory received 283,394 clinical samples for mycobacterial 
culture. From a total of 23,499 (8.3%) specimens with posi-
tive mycobacterial culture results, M. tuberculosis were 
isolated from 14,295 (5.0%) specimens from 3,695 patients 
and NTM were isolated from 9,204 (3.2%) specimens from 
4,786 patients. The trends of decreasing M. tuberculosis 
isolation and increasing NTM isolation were signiﬁ  cant 
(p<0.05 for each) (Figure, panel A). 
Among the 9,204 NTM isolates, M. avium complex 
(MAC, 30.0%) were the most frequently isolated organ-
isms, followed by M. abscessus (17.5%), M. fortuitum com-
plex (13.0%), M. chelonae complex (9.6%), M. kansasii 
(5.6%), and M. gordonae (5.5%) (Table). Among NTM 
isolates from the 4,786 patients, prevalent species were 
MAC (31.7%), M. fortuitum complex (18.2%), M. absces-
sus (17.2%), M. gordonae (11.6%), M. chelonae complex 
(8.2%), and M. kansasii (6.0%) (Table). In addition, some 
rare isolates such as M. celatum (n = 3), M conceptionene 
(n = 3), M. neoaurum (n = 2), M. arupense (n = 1), M. 
mageritense (n = 1), M. asiaticum (n = 1), and M. immuno-
genum (n = 1) were identiﬁ  ed.
Annual incidences are shown in the Figure, panels B 
and C. During the study period, the proportions of NTM 
and rapidly growing mycobacteria among all mycobacte-
ria isolated increased signiﬁ  cantly from 32.3% to 49.8% 
(p<0.05) and from 3.7% to 23.4% (p<0.05), respective-
ly. Incidence of diseases caused by NTM also increased 
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(p<0.0001) from 2.7 to 10.2 per 100,000 inpatients and out-
patients. The incidences of pulmonary and extrapulmonary 
NTM infection signiﬁ  cantly increased from 1.26 to 7.94 
per 100,000 inpatients (p<0.0001) and from 1.4 to 2.23 per 
100,000 outpatients (p = 0.0194), and the increase of all 
NTM diseases was predominately in pulmonary diseases. 
During the 9 years, 1,105 patients had NTM diseases; most 
commonly pulmonary disease (n = 894, 76.8%), followed 
by soft tissue infection (n = 122, 11.4%), disseminated in-
fection (n = 79, 7.1%), and peritonitis (n = 19, 1.7%). MAC 
was the most common cause of pulmonary infection (n = 
342, 40.3%) and disseminated infection (n = 56, 70.1%); 
M. abscessus was the most common cause of skin and soft 
tissue infection (n = 46, 37.7%).
Conclusions
During the 9-year period, NTM accounted for 39.2% 
of positive mycobacterial cultures and increased signiﬁ  -
cantly. In concordance with the increased incidence of 
NTM isolations, incidence of NTM diseases also increased 
signiﬁ  cantly. The increase of NTM isolations since 2002 
might have resulted from use of the BACTEC system. This 
apparent increase in NTM disease could also be attributed 
to increasing vigilance and awareness of these bacteria as 
human pathogens, improved methods of detection, or more 
immunocompromised hosts (e.g., as a result of tumor ne-
crosis factor inhibitors, human interleukin 1 receptor an-
tagonists, and anti-CD20 antibodies) (1,8).
Prevalence of mycobacteria species responsible for 
different diseases varies markedly by geographic region. In 
the United States and Japan, MAC and M. kansasii are the 
most common species (4), whereas in England and Scot-
land, M. kansasii and M. malmoense, respectively, are the 
most common (9). Our study showed that MAC was the 
most common NTM species in Taiwan, followed by M. ab-
scessus. The most common organism in localized pulmo-
nary infection and disseminated infection was MAC, and 
M. abscessus predominated in skin and soft tissue infection 
and lymphadenitis, consistent with ﬁ  ndings of a previous 
study in Taiwan (2). Thus, M. abscessus deserves as much 
attention as MAC, especially for extrapulmonary NTM dis-
ease, in Taiwan.
Identiﬁ  cation of clinical isolates beyond the genus level 
is crucial because NTM species differ in the clinical spec-
trum of the diseases they cause and in their susceptibility 
to antimicrobial drugs. Previous studies have demonstrated 
that the rare strains identiﬁ  ed in this study are pathogenic 
and cause human infections, e.g., 1 case of catheter-related 
bloodstream infection caused by M. neoaurum, 1 case of 
pulmonary infection caused by M. celatum, and 2 cases of 
soft tissue infection caused by M. conceptionene and M. 
arupense (10–13). In addition, in this study M. mageritense 
and M. immunogenum were the causative agents for pulmo-
nary infection in an adult and submandibular abscess in a 
child from Taiwan, respectively.
One study limitation was lack of a quantiﬁ  able de-
nominator, which is critical for understanding the epide-
miology of an illness. True population-based inferences 
about NTM epidemiology are usually impossible to con-
clude from a study of only hospital inpatients and outpa-
tients. Although the hospital has a reference mycobacteri-
ology laboratory and is a major referral center in Taiwan, 
how the study sample may have affected the results or the 
approximate size of its catchment of patients remains un-
known. During the study period, an increasing percentage 
of patients (≈20% in 2008) was referred from other hos-
pitals in different parts of Taiwan. However, because this 
study was conducted in a tertiary-care center in northern 
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Figure. Incidence data for clinical samples submitted for 
mycobacterial culture, National Taiwan University Hospital, Taipei, 
Taiwan, January 2000–December 2008. A) Annual number and 
rate of isolates of nontuberculous mycobacteria (NTM) (triangles) 
and Mycobacterium tuberculosis (circles). B) Annual incidence of 
isolates of NTM, M. avium complex (MAC), and rapidly growing 
mycobacteria (RGM). C) Annual incidence of NTM disease, 
pulmonary disease, and extrapulmonary disease.Taiwan, these ﬁ  ndings might not reﬂ  ect the overall situa-
tion in Taiwan.
As prevalence and incidence of NTM increases, clini-
cians in Taiwan should consider NTM as a possible cause 
of TB-like disease. Accurate species identiﬁ  cation is im-
perative before proper treatment can be determined for 
diseases caused by the diversity of NTM species. Further 
studies of clinical isolates are also needed to understand the 
spectrum of disease caused by these rare pathogens.
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Table. Frequently isolated nontuberculous mycobacteria, Taiwan  
Year, no. isolates/no. patients (% isolates/% patients) Bacterial 
species 2000 2001 2002 2003 2004 2005 2006 2007 2008
Mycobacterium 
avium complex
102/50
(28.5/25.3)
38/23
(10.1/10.1)
244/134
(28.7/27.6)
328/154
(36.7/38.3)
340/158
(25.6/23.2)
449/246
(40.1/44.7)
314/199
(32.7/34.6)
375/242
(26.3/33.8)
571/309
(29.7/32.1)
Mycobacterium 
abscessus
60/36
(16.8/18.2)
94/51
(24.9/23.3)
123/69
(14.6/14.2)
139/63
(15.6/15.6)
163/85
(12.3/12.5)
181/91
(16.5/16.5)
199/98
(20.7/17.0)
250/140
(16.9/19.6)
400/191
(20.8/19.8)
Total 358/198 378/219 841/485 893/402 1,327/679 1,098/550 961/575 1,424/716 1,924/962